Metagenomi (MGX) Income Statement: Revenue & Earnings

Metagenomi Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Metagenomi, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	52.30	44.76	17.20	0.24
Cost of Revenue	0.00	94.40	43.14	14.48
Gross Profit	52.30	-49.65	-25.94	-14.24
Operating Expenses
Research & Development	109.18	94.40	43.14	14.48
Selling, General & Administrative	32.02	28.85	18.70	9.71
Operating Expenses	141.20	28.85	61.84	24.19
Operating Income	-88.90	-78.49	-44.64	-23.95
Other Income/Expense
Interest Income	14.72	15.47	3.42	0.04
Interest Expense	0.00	0.00	0.10	0.30
Other Income/Expense	5.33	-0.07	0.30	2.76
Income
Income Before Tax	-83.57	-60.23	-41.02	-21.44
Income Tax Expense	-5.51	8.03	2.57	0.00
Net Income	-78.06	-68.26	-43.59	-21.44
Net Income - Continuous Operations	-78.06	-68.26	-43.59	-21.44
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-83.49	-74.29	-39.19	-20.75
EBIT	-83.57	-78.49	-40.93	-21.14
Depreciation & Amortization	5.41	4.21	1.73	0.39
Earnings Per Share
Basic EPS	-2.00	-20.00	-1.00	-1.00
Diluted EPS	-2.00	-20.00	-1.00	-1.00
Basic Shares Outstanding	37.42	3.40	29.96	29.96
Diluted Shares Outstanding	37.42	3.40	29.96	29.96